Balloon Eustachian tuboplasty (BET) in children
Potential of side-controlled clinical trials to examine effectiveness
- 22.01.2021
- letter to the editors
- Verfasst von
- Gerold Besser, MD, PhD
- Valerie Dahm, MD
- Dominik Riss, MD
- Stefan Flak
- Christoph Arnoldner, MD
- Erschienen in
- Wiener klinische Wochenschrift | Ausgabe 13-14/2021
Auszug
Efficacy and long-term outcome of balloon Eustachian tuboplasty (BET) are debated controversially, as high quality prospective controlled studies in this area remain sparse [1]. In children chronic otitis media with effusion (COME) is a common and often recurrent problem even after first-line treatment involving adenoidectomy (AT) and paracentesis (PC) with or without ventilation tube (VT). Eustachian tube dysfunction (ETD) is considered to be partly causative and retrospective data on BET in children show promising results [2, 3]. With sham surgery being unethical and a large heterogeneity in disease severity in ETD among patients of all ages, study planning is challenging. Although alternative approaches have been advocated (delayed start design, see [4]), the ears provide the possibility of a within-patient control. …
Anzeige
- Titel
-
Balloon Eustachian tuboplasty (BET) in children
Potential of side-controlled clinical trials to examine effectiveness - Verfasst von
-
Gerold Besser, MD, PhD
Valerie Dahm, MD
Dominik Riss, MD
Stefan Flak
Christoph Arnoldner, MD
- Publikationsdatum
- 22.01.2021
- Verlag
- Springer Vienna
- Erschienen in
-
Wiener klinische Wochenschrift / Ausgabe 13-14/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671 - DOI
- https://doi.org/10.1007/s00508-020-01803-w
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.